<DOC>
	<DOCNO>NCT02088060</DOCNO>
	<brief_summary>Schizophrenia heterogeneous mental disorder affect one percent world 's population . Current antipsychotic partially effective , use often associate serious side effect . Cannabidiol natural counterpart psychoactive component marijuana , delta-9-tetrahydrocannabinol . While cannabidiol psychotomimetic addictive property , indirectly affect endogenous cannabinoid signal impair degradation endocannabinoid anandamide . In controlled clinical trial cannabidiol versus amisulpride ( establish antipsychotic ) acute paranoid schizophrenic investigator show significant clinical improvement symptom schizophrenia compare baseline either treatment . But cannabidiol displayed significantly superior side-effect profile . This study evaluate efficacy safety novel treatment option comparison placebo olanzapine , establish second generation antipsychotic treatment acute schizophrenia schizophrenia maintenance therapy , four-week clinical trial .</brief_summary>
	<brief_title>A Four-week Clinical Trial Investigating Efficacy Safety Cannabidiol Treatment Acutely Ill Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Informed consent give subject DSMIVTR diagnosis schizophrenic psychosis ( 295.10 , 295.20 , 295.30 , 295.90 ( American Psychiatric Association ) Patients must within first three year illness , i.e . first diagnosis schizophrenia old three year . Age 18 65 year , male female Minimal initial PANSS score 75 baseline Female patient childbearing potential need utilize proper method contraception . Body Mass Index 18 40 Lack accountability ( assessed independent psychiatrist ) History treatmentresistant schizophrenia , define response least two antipsychotic give minimum 6 week adequate dosage Positive urine drugscreening illicit drug screen ( except cannabinoids benzodiazepine ) Serious suicidal risk screen visit ( Subject investigator 's independent psychiatrist 's judgement : Poses serious suicidal homicidal risk screen visit make serious suicide attempt within last 12 month prior screen visit , exhibit homicidal behaviour anytime her/his lifetime ) Known intolerance allergy olanzapine cannabidiol Other relevant interference axis 1 ( e.g . serious depression ) accord diagnostic evaluation ( MINI ) include residual form schizophrenia Pregnancy , determine Î²HCG pregnancy test , lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>